​

Aptevo Therapeutics Ownership | Who Owns Aptevo Therapeutics?

OverviewFinancialsChart

Aptevo Therapeutics Ownership Summary

Aptevo Therapeutics is owned by 5.07% institutional investors, 0.06% insiders, and 94.87% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.06% of its assets in Aptevo Therapeutics shares.

APVO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAptevo Therapeutics5.07%0.06%94.87%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20269-10.00%53,750164.87%5138.44%775.00%--100.00%
Dec 31, 202510-16.67%20,293-95.89%128.58%4-55.56%5400.00%
Sep 30, 20251271.43%493,9973185.65%241749.05%9200.00%1-75.00%
Jun 30, 20257-12.50%15,035-23.40%-300376.47%3-40.00%4300.00%
Mar 31, 20258-38.46%19,629-59.52%-3187.40%5-28.57%1-83.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr12.71K1.06%-
Fidelity Extended Market Index8.93K0.76%158.00
Spartan Extended Market Index Pool F2.20K0.19%2.18K
Abante Quant Value FI1.76K0.18%-
Fidelity Series Total Market Index1.55K0.13%681.00
Spartan Total Market Index Pool G658.000.06%-
Northern Trust Wilshire 500032.000.00%32.00
NT US Market Cap Idx Fd - L32.000.00%-
NT US Market Cap Index Fund - Ld32.000.00%-
Spartan Extended Market Index Pool E807.000.00%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 10, 2025Grant Grady III-Buy$20.13K
Jun 14, 2019Niederhuber John-Buy$649.74
Nov 23, 2021TANG KEVIN C-Sell$1.55M
Nov 23, 2021TANG KEVIN C-Sell$886.43K
Nov 23, 2021TANG KEVIN C-Sell$2.18M

Insider Transactions Trends

DateBuySell
2025 Q41-
2025 Q3--
2025 Q1--
2024 Q3--
2024 Q2--

APVO Ownership FAQ

Who Owns Aptevo Therapeutics?

Aptevo Therapeutics shareholders are primarily institutional investors at 5.07%, followed by 0.06% insiders and 94.87% retail investors. The average institutional ownership in Aptevo Therapeutics's industry, Biotech Stocks , is 35.75%, which Aptevo Therapeutics falls below.

Does Blackrock own Aptevo Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aptevo Therapeutics.

Who is the top mutual fund holder of Aptevo Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Aptevo Therapeutics shares, with 1.06% of its total shares outstanding invested in 12.71K Aptevo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools